These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6753900)

  • 21. [Renin-angiotensin system antagonists].
    Ogawa M; Inagaki Y
    Nihon Rinsho; 1983 Dec; 41(12):2703-8. PubMed ID: 6371300
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
    Ourbak P; Pornin M; Melanidis J; Bouziri S; Allal J; Sellier P; Maurice P
    Arch Mal Coeur Vaiss; 1984 Aug; 77(8):865-71. PubMed ID: 6435565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
    Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The hemodynamic effect of Capoten in patients with myocardial infarct complicated by heart failure].
    Iaremenko OB; Netiazhenko VZ; Emchenko IR; Kurochko VB
    Vrach Delo; 1989 Nov; (11):44-7. PubMed ID: 2692289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril in congestive heart failure.
    Liebau G; Riegger AJ; Schanzenbächer P; Steilner H; Oehrlein S
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):193S-199S. PubMed ID: 6753901
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of the treatment of heart failure with captopril].
    Morand P; Lavigne G
    Nouv Presse Med; 1981 Apr; 10(19):1591. PubMed ID: 7025851
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
    Sharpe DN; Coxon RJ
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
    Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
    Pfeffer MA; Pfeffer JM; Steinberg C; Finn P
    Circulation; 1985 Aug; 72(2):406-12. PubMed ID: 3891136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Captopril in the treatment of chronic congestive heart failure].
    Grajek S; Jasiński K
    Kardiol Pol; 1984; 27(3):225-41. PubMed ID: 6376905
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies of left ventricular dysfunction following myocardial infarction.
    Sharpe N
    Herz; 1991 Sep; 16 Spec No 1():272-7. PubMed ID: 1820293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Favorable hemodynamic effects of captopril in chronic refractory cardiac decompensation].
    Ansalone G; Bellocci F; Scabbia E; Schiavoni G; Loperfido F; Zecchi P
    Cardiologia; 1982; 27(3):263-9. PubMed ID: 6765277
    [No Abstract]   [Full Text] [Related]  

  • 36. [Captopril (Capoten) in the treatment of heart insufficiency].
    Rømer FK
    Ugeskr Laeger; 1984 Feb; 146(6):445-7. PubMed ID: 6367180
    [No Abstract]   [Full Text] [Related]  

  • 37. Captopril therapy for heart failure. A placebo controlled study.
    Cowley AJ; Rowley JM; Stainer KL; Hampton JR
    Lancet; 1982 Oct; 2(8301):730-2. PubMed ID: 6125809
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
    Kramer BL; Massie BM; Topic N
    Circulation; 1983 Apr; 67(4):807-16. PubMed ID: 6337741
    [No Abstract]   [Full Text] [Related]  

  • 39. [Captopril (Tensobon) in practical use in hypertension and heart failure].
    Philipp T; Lederle RM
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S15-23. PubMed ID: 6424002
    [No Abstract]   [Full Text] [Related]  

  • 40. Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril.
    Ikram H; Maslowski AH; Nicholls MG
    Br Heart J; 1981 Nov; 46(5):528-30. PubMed ID: 7032556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.